Report #2829770

Received Mar 5, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: NV
Recovered: Unknown
Vaccinated: Jan 1, 2025
Onset: Jan 1, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	1	—	—

Symptoms (1)

Dizziness

Symptom narrative

Dizziness; Initial report received on 24-Feb-2025. A nurse reported that a 26-year-old female (race, ethnicity not reported) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization and experienced dizziness. No medical history or concomitant medications were reported. In Jan-2025, the patient received dose 1 of a hepatitis B vaccine [HEPLISAV-B (lot #, expiration date, NDC #, route, and site not available)]. On an unknown date, a week after the first dose of HEPLISAV-B, the patient experienced dizziness. The patient is due for her second dose but has been referred to her primary care provider for follow-up. No additional information was provided. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.